Phillips Pharmaceuticals (Nigeria) Limited RC COMPANY PROFILE

Similar documents
CHRO N I C DIS EAS ES A HEALTH SYSTEMS APPROACH TO CHRONIC DISEASES. Stronger health systems. Greater health impact.

Corporate Brochure RECRUITMENT

Senior Research, Measurement and Evaluation Officer (based in Abuja) Project: SIFPO/LEAP Project

Emergency Care in sub- Saharan Africa: Innovations and Challenges

Business Coalitions- Mediators for TB care and control

EIT HEALTH WILD CARD PROJECTS CALL FOR APPLICATIONS 2018

presents OHIO biomedical and pharma career fair April 15 2pm 6pm Columbus, Ohio Exhibitor Booklet

Africa in Focus. Africa

REPOSITIONING OUR CLINICAL LABORATORIES FOR EFFECTIVE AND EFFICIENT HEALTHCARE DELIVERY. By Prof. Ibironke Akinsete Chairman PathCare Nigeria

Public health, innovation and intellectual property: global strategy and plan of action

26 th Annual Cardiology and Cardiovascular Nursing Congress

Strengthening Local Pharmaceutical Production in Africa to improve and sustain Access to Medicines

AFFORDABLE MEDICINES FACILITY MALARIA

Sudanese National Academy of Sciences (SNAS) Sep 2016 Prof. Suad Sulaiman, INGSA, Brussels 1

November 2013 SALES BROCHURE Nairobi, Kenya

Grant Aid Projects/Standard Indicator Reference (Health)

Economic Burden of Counterfeit Medicine in Africa: Situation Analysis and Proposed Solution

WHO World Alliance for Patient Safety Conference. Official opening by Hon Charity K Ngilu MP, Minister for Health.

SENIOR EXPERTS DIALOGUE ON SCIENCE, TECHNOLOGY AND INNOVATION AND THE AFRICAN TRANSFORMATION AGENDA

Primary health care reform in Ukraine: priorities and perspectives

Pushing the boundaries of exquisite medical care 30 YEARS. of excellence PATIENT-CENTRED COMPASSION DRIVEN INTERNATIONAL PRACTICE

An integrated approach to Laboratory Systems Strengthening. Rosemary Emodi International Manager

Digital health at scale: Key considerations for developing markets

SESSION #6: DESIGNING HEALTH MARKET INTERVENTIONS Part 1

Developing Africa s capacity in mathematical sciences: The Journey of AIMS

Wendy Telgt-Emanuelson MPH, BSc Acting Head Department of Research, Planning & Monitoring Miriam Naarendorp Msc, RPh Pharmacy Policy Coordinator/

6,000+ 2,500+ sqm Meet the food and drink industry in Africa s richest economy

Pharmacy, Medicines and You. Principal Pharmacist Pharmaceutical Services Deputy Director of Pharmacy and Medicines Management

CONNECTING LEADERS THE FOUR SEASONS RESORT AT JUMEIRAH BEACH PROGRAMME

Acceleration in Sub-Saharan Africa

Title: Nestlé Equatorial African Region an overview. Name: Pierre Trouilhat. Date: 28th January 2011

Compendium of Investment Projects. Healthcare & Biotech

Conclusion: what works?

Pharmaceutical & Surgical Wholesalers & Distributors. Presentation prepared for Day Hospital Association Conference

BIRAC announces launch of. SPARSH Touching a Billion Lives. Social Innovation programme for Products: Affordable & Relevant to Societal Health

Beating the benchmark

Improving Access to Medicines Project in the Philippines the Palawan Pilot:

Investor Presentation

Co C as a t s Pro r v o i v nce nc G eneral Hospi s tal Le L v e e v l 5 R 5 e R fe f rr r al a F ac a i c lity *** 9/2/2015 1

Kaiser Permanente Research A Very Brief Introduction

Access to healthcare highlights. Key challenges

WEST AFRICA INSIDE THE THE AFRICAN MARKET. International Business and Investment Forum UN Campus, Bonn, Germany, 1st to 2nd March 2018

Regional Network for Drugs and Diagnostics Innovation exemplified by ANDI. Background Paper for Executive Board

Nicole Bartley Charles Adeyanju

TERMS OF REFERENCE CREDIT MARKET DEVELOPMENT PROGRAMME PROJECT MANAGER

SLMTA/SLIPTA Symposium November 28-29, 2014 Cape Town, South Africa. A satellite meeting to the ASLM2014 Conference.

Pharmacovigilance in Africa Contributing Factors for it s development

July Innovations Against Poverty Analysis of Cycle 2

MEASURE DHS SERVICE PROVISION ASSESSMENT SURVEY HEALTH WORKER INTERVIEW

Affordable Medicines Facility - malaria

OMC Strategic Plan Final Draft. Dear Community, Working together to provide excellence in health care.

Health and Life Sciences Committee. Advancing the ASEAN Post-2015 Health Development Agenda

Trends in medical tourism

Slide1 Lessons Learned -

For personal use only

The recommendations in How Can We Avoid a Stroke Crisis? are endorsed by the following organisations:

FINAL STATEMENT BY THIRD APEC HIGH LEVEL MEETING ON HEALTH AND THE ECONOMY

NEW EMPLOYEE HEALTH PLAN BENEFIT. Care When You. Need

Oumkaltoum Lahlou Head of Regulatory Affairs North & West Africa, Merck Group, Darmstadt, Germany

Family Practice Clinic

Government takes over TB medicines supply in Moldova: way forward

Entrepreneurship Education for Scientists and Engineers in Africa 92

THE AFRICAN MEDICINES REGULATORY HARMONIZATION (AMRH) INITIATIVE Accomplishments, Challenges and Path Forward

MAKING SENSE OF YOUR FUTURE

I Russia I Ukraine I Kazakhstan I Uzbekistan I Belarus I Turkmenistan I Azerbaijan I Moldova I Kyrgyzstan I Georgia I Tajikistan I Armenia

Greek-German Cooperation for Research and Innovation. Theodore Tryfon Co-CEO ELPEN Group President, PanHellenic Union Of Pharmaceutical Industries

IST-Africa Initiative. Supporting the Evolution of Sustainable Living Labs and Living Labs Networks in Africa

RWANDA S COMMUNITY HEALTH WORKER PROGRAM r

Seed Grant Recipients by College

The ultimate objective of all of our development assistance is to improve the quality of life for Africans.

RESEARCH SERVICE PROVIDER CLINICAL SUPPORT SERVICES HEALTH OUTCOMES SOLUTIONS

Invest for Impact: Global Fund Session. 29 th Stop TB Partnership Coordinating Board Meeting Berlin 17 th May

PRESS RELEASE 20 youth emerge as winners of the first ever Africa Youth in Agribusiness Day Challenge. Accra, Ghana. 23 rd October 2017 An

CO-LOCATES WITH: MINI & OFF GRID SUMMIT. Taking energy to the greatest destination on earth

Investor Presentation Q1 FY 2017

Arab Expatriate Scientists and the Science and Technology Revolution in the Arab World

Forward-Looking Statements

On Site Health Clinics: Effectively Managing Initial Costs and Incorporating Innovative/Effective Programs

EDCTP2 - Opportunities for clinical research on poverty-related diseases in sub-saharan Africa.

Building the Next Metropolitan Centre. The City of Surrey Economic Strategy Overview

Teaching Global Health Through an Interprofessional Lens

FlandersBio and Flemish Life Science Cluster Strategy. State of the Union, May 25th 2016

The European network evaluation of the PHAR QA framework of competences for...

AFRICAN HEART NETWORK. Contribution of AHN in policy implementation for the control of CVD in Africa Pr Habib Gamra

PROGRAM BRIEF UGANDA. Integrated Case Management of Pneumonia, Diarrhea & Malaria through the Five & Alive Franchise Network

Leveraging Existing Laboratory Capacity towards Universal Health Coverage: A Case of Zambian Laboratory Services

Dr. AM Abdullah Inspector General, MOH THE HEALTH SITUATION IN IRAQ 2009

Stichting IplusANBI 2017 Activity Plan. Table of Contents

THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (LATIN AMERICA EDITION)

Birmingham Solihull and the Black Country Area Team

Background 11/14/14. Purpose of Survey. Presenter Disclosures. Tara Ray

Primary Health Care Services UNRWA. June 23, 2011

COMMONWEALTH HEALTH MINISTERS MEETING Sunday 20 May 2012 Geneva, Switzerland

YOUR TRUSTED HEALTH COMPANION. A plan for life.

Our MISSION is to ensure that the benefits outweigh the risks for all medical radiation exposures in Africa.

Corporate Profile. December 2017

Regulatory Control of Diagnostics in Tanzania. Hiiti Sillo Ag. Director General Tanzania Food and Drugs Authority

Integra. International Corporate Capabilities th Street NW, Suite 555W, Washington, DC, Tel (202)

April L. Lyons, MSN, RN Director of Clinical Operations Westside Family Healthcare

Regulatory Networks. Regulatory Capacity Building Workshop: Vaccine Clinical Trial Review from Ebola to HIV March 2015 Kigali, Rwanda

Transcription:

COMPANY PROFILE A glimpse into the history and current operations of Phillips Pharmaceuticals Ltd. The past: Phillips International limited (formerly known as Phillips Harrison & Crossfield Limited), was acquired by the current shareholders. Thus Phillips Pharmaceuticals Limited was instituted in 1991 based in Nairobi,. The Present: Phillips Pharmaceuticals with its Head-Quarters in Nairobi has spread its wings to the other East African Markets and West Africa. Our various country operations are Phillips Pharmaceuticals Limited Pharma Specialties Limited Phillips Healthcare Services Ltd. Phillips Healthcare Technologies Limited Star Pharmaceuticals Limited Phillips Distributors Limited Phillips Pharmaceuticals Rwanda Limited Phillips Pharmaceuticals Zambia Limited Phillips Pharmaceuticals Ghana Limited Phillips Pharmaceuticals (Nigeria) Limited Uganda Tanzania Rwanda Zambia Ghana Nigeria

About Us: Phillips Pharmaceuticals Group employs a total of 1000 employees in Africa. The group represents over 45 internationally recognized research based pharmaceutical companies, manufacturing pharmaceuticals, nutritional, diagnostics and medical imaging products.. Phillips Pharmaceuticals Limited has been assigned the responsibility of safe and effective distribution of the ARV s in the African Market under PEPFAR scheme. Our Core Competencies: The senior Management at Phillips Pharmaceuticals Limited comprises of highly motivated professionals with over three decades of pharmaceutical and related business expertise. The group employs well- qualified and experienced professionals in the field of sales, marketing, recruitment, finance, administration, procurement, distribution and other related activities to provide uninterrupted efficient service. The strength of the group lies in the ability to partner with the global business leaders in the pharmaceutical industry and implement the strategies to provide effective market penetration for their products. The most valuable asset and strength of the group is its people. This belief of the group attracts young talent to Phillips Pharmaceuticals Limited where we train them effectively. The group has modern warehousing facilities in accordance with the EU- GDP guidelines and excellent distribution and MIS system to help take the right decisions at the right time to improve productivity of each of our business partners.

From East to West We have taken another quantum leap into the horizon of opportunities by incorporating Phillips Pharmaceuticals Nigeria Limited, with the base in Lagos, in the year July 2005. Phillips Pharmaceuticals Nigeria Limited, once a small sapling, today has become the most coveted name in the Nigerian Pharmaceuticals domain, known to be a melting port of international and indigenous expertise. PPNL premise comprises of a huge 25,000 square feet area inside Afprint industrial Estate, Lagos. It has a highly modernized, fully equipped warehousing facility and state of the art offices and training center. Presently a dedicated team of ten expatriate managers and 160 plus indigenous staff with specialized skills provide round the clock services to the huge customer base, comprising of major Teaching hospitals, State and community hospitals, private clinics distributors and pharmacies across the country. Our expertise is in the arena of marketing the finished formulations through dedicated field force for each individual company that are registered with us. Key Partners We are fully operational with many Trans-national organizations namely-novartis, Abbott, Agio, Ascent Meditech, Aurobindo, Bharat Biotech (Vaccines), Biotech VisionCare, Bottu (Morocco), Cipla, Gilead Sciences Inc, Indoco, Innotech Laboratories, Intas, Lupin, Mankind, Menarini, Modi Mundi, MSN, Prisma Pharmaceuticals, Sanofi, Troikaa, Unichem, etc Our Goal To provide better healthcare governance by improving the distribution and marketing of Pharmaceuticals and allied range of products in Nigeria

Our Vision Phillips Pharmaceuticals (Nigeria) Limited To provide novel therapies, by partnering with Major Pharmaceutical Players around the Globe, for better patient care, help shorten Hospital stay, reduce costs and improve the Quality of lives in Nigeria Our Strength & Focus Present in the field of Malaria; Infections; Diabetes; Cardiology; HIV; Gastro-intestinal; Haematanic; Other unique preparations Unique areas of healthcare delivery (Cardio-Metabolics; Diabetes; Oncology; Rapid Diagnostic Test Kits) Represent the WHO pre-qualified products Our distribution network is Pan Nigeria We handle COLD CHAIN products like Vaccines and Recombinant Epidermal growth factor We conduct Various CME s for Hospitals; Health institutions; Patient education CMEs for increasing health awareness Our Initiatives: Amongst the list of various initiative of Phillips in healthcare support programs like Malaria; Diabetes; Hypertension; Oncology; Eye care etc. one of the current initiative is Hepatitis. We initiated this activity from World Hepatitis day 2015 Hepatitis Awareness Campaign: With an objective to increase awareness of Hepatitis in Nigeria Phillips Pharmaceuticals (Nigeria) conducts the Awareness camps throughout the nation. Hepatitis Vaccination camps : As a follow up of this campaign Phillips conducts Hepatitis Vaccination camps nationwide at affordable cost. We also welcome all those who are interested to support this campaign in increasing awareness on Hepatitis by partnering with us in this mission.

Awards & Rewards: Award for Excellence 2013 by National Association for Lab Scientist Abia State. Winner of Best Diabetic Management Drugs 2011 by Institute for Govt. Research and Leadership technology Winner of West Africa s Antibiotic Drugs of the year by Institute of Direct Marketing in Nigeria. West African Direct Marketing Award Best Company Award 2012 by Guild of Lab Scientists Our Product Range: Anti-Malarial Antibiotics Anti-retroviral Cardiovascular products Anti Diabetics Gastro-intestinal Cough Expectorants. Haematinics NSAIDS Ortho Clinical Products (Blood Bank) Ophthalmic /VisionCare Products Medical device/ Medical Consumables e.g. Sutures Micronutrients (Amino Acids and Multivitamins) And Calcium Preparations. 2-8 Degree Cold Chain Products Like: Vaccines and Recombinant Human Epidermal Growth Factor. Phillips Pharmaceuticals ( Nigeria) Limited